Artiva Biotherapeutics Inc. (ARTV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Artiva Biotherapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Artiva Biotherapeutics Inc. (ARTV) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $209M. It trades at $4.28, up 0.12% today. Its overall quality score is 44 out of 100, ranked against the whole US market. 5 analysts' average target of $11.00 implies +157.0% from today's price. Kronos AI's 30-day forecast is +114.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $11.00 |
| Low – high | $1.00 – $35.00 |
| Analysts | 5 |
| Upside to average | +157.0% |
Kronos AI 30-day forecast
| Expected close | $9.14 (+114.1%) |
| Likely range | +99.4% … +142.0% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 41 |
| Solvency | 61 |
| Growth | 30 |
| Overall | 44 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator